论文信息 - Acute coronary occlusion following TAVI

Acute coronary occlusion following TAVI

Transcatheter aortic valve implantation (TAVI) has nowadays replaced open heart surgery as an alternative therapeutic tool in selected patients. Thirty‐five percent of patients with severe degenerative aortic valve stenosis (AS) remain untreated because of the existing comorbidities that increase their perioperative risk. TAVI is a relatively new technique that has “come to stay” in the everyday clinical practice considering, that is the only alternative to surgery and appears to have excellent long term results. Herein, we describe a vascular complication immediately after the implantation of the Edwards SAPIEN (Edwards Lifesciences, Irvine, CA) prosthesis, followed by ad hoc percutaneous coronary intervention. © 2010 Wiley‐Liss, Inc.

B. Gogas | A. Antoniadis | A. Zacharoulis | Bill D. Gogas | Achilleas A. Zacharoulis

[1] E. Stabile,et al. Acute left main obstructions following TAVI. , 2010 .

[2] A. Cribier,et al. Outcomes and safety of percutaneous aortic valve replacement. , 2009, Journal of the American College of Cardiology.

[3] C. Ruiz,et al. Percutaneous transcatheter aortic valve implantation: assessing results, judging outcomes, and planning trials: the interventionalist perspective. , 2008, JACC. Cardiovascular interventions.

[4] Y. Aggoun,et al. Aberrant right coronary artery occlusion during the percutaneous pulmonary trunk stenting in a patient with tetralogy of Fallot , 2008, Heart and Vessels.

[5] J. Webb. Percutaneous aortic valve replacement will become a common treatment for aortic valve disease. , 2008, JACC. Cardiovascular interventions.

[6] M. Kern,et al. Acute myocardial infarction during percutaneous aortic balloon valvuloplasty. , 1988, Catheterization and cardiovascular diagnosis.